Loading...
Characterization of T-cell immune responses in clinical trials of the candidate RTS,S malaria vaccine
The candidate malaria vaccine RTS,S has demonstrated 45.7% efficacy over 18 months against all clinical disease in a phase-III field study of African children. RTS,S targets the circumsporozoite protein (CSP), which is expressed on the Plasmodium sporozoite during the pre-erythrocyte stage of its li...
Na minha lista:
| Udgivet i: | Hum Vaccin Immunother |
|---|---|
| Main Authors: | , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Taylor & Francis
2017
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5791571/ https://ncbi.nlm.nih.gov/pubmed/28934066 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/21645515.2017.1381809 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|